WELL Health Technologies Corp. (TSX:WELL)
Canada · Delayed Price · Currency is CAD 4.590
+0.210 (4.79%)
Jun 1, 2026, 4:00 PM EST
WELL Health Technologies Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 41.02 | 4.46 | 29.1 | 16.64 | 18.68 | -31.29 |
Depreciation & Amortization | 99.79 | 93.76 | 72.31 | 60.77 | 55.2 | 38.71 |
Stock-Based Compensation | 15.31 | 22.69 | 15.27 | 26.16 | 24.48 | 21.01 |
Other Adjustments | -2.78 | 37.68 | -113.12 | -27.58 | -16.74 | 5.13 |
Changes in Other Operating Activities | -58.47 | -36.7 | 6.67 | -10.25 | -5.08 | -11.3 |
Operating Cash Flow | 115.51 | 121.89 | 9.52 | 66.44 | 76.55 | 22.27 |
Operating Cash Flow Growth | - | 1180.07% | -85.67% | -13.21% | 243.75% | - |
Capital Expenditures | -32.64 | -27.87 | -16.23 | -8.11 | -6.4 | -2.68 |
Purchases of Investments | -0.63 | -7.44 | -0.07 | -6.64 | - | -3.12 |
Proceeds from Sale of Investments | 15.1 | 15.1 | 2.39 | 11.56 | 16.51 | - |
Payments for Business Acquisitions | -51.67 | -59.72 | -37.2 | -66.14 | -16.51 | -491.22 |
Other Investing Activities | -27.52 | -11.03 | -9.12 | -11.99 | -31.53 | -2.76 |
Investing Cash Flow | -85.79 | -90.95 | -60.23 | -81.32 | -37.93 | -499.78 |
Long-Term Debt Issued | 159.61 | 147.17 | 46.69 | 106.86 | 48.73 | 211.76 |
Long-Term Debt Repaid | -48.68 | -49.07 | -78.06 | -55.51 | -97.94 | -35.54 |
Net Long-Term Debt Issued (Repaid) | 110.93 | 98.11 | -31.36 | 51.36 | -49.21 | 176.22 |
Issuance of Common Stock | 0.33 | 0.45 | 3.22 | 0.81 | 35.68 | 303.13 |
Repurchase of Common Stock | -2.26 | -1.83 | -1.66 | - | -0.24 | - |
Net Common Stock Issued (Repurchased) | -1.92 | -1.38 | 1.56 | 0.81 | 35.44 | 303.13 |
Issuance of Preferred Stock | - | 58.32 | 47.65 | - | - | - |
Net Preferred Stock Issued (Repurchased) | - | 58.32 | 47.65 | - | - | - |
Other Financing Activities | -143.23 | -180.99 | 115.66 | -41.54 | -39.08 | -26.82 |
Financing Cash Flow | 3.51 | -25.95 | 133.5 | 10.63 | -52.85 | 452.53 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -2.39 | -2.91 | 4.75 | -0.53 | 1.22 | 0.01 |
Net Cash Flow | 30.84 | 2.09 | 88.25 | -5.49 | -13.01 | -24.97 |
Free Cash Flow | 82.87 | 94.02 | -6.7 | 58.33 | 70.14 | 19.59 |
Free Cash Flow Growth | -11.86% | - | - | -16.84% | 258.12% | - |
FCF Margin | 5.62% | 6.71% | -0.73% | 7.52% | 12.32% | 6.48% |
Free Cash Flow Per Share | 0.33 | 0.37 | -0.03 | 0.25 | 0.32 | 0.10 |
Levered Free Cash Flow | 146.43 | 119.94 | 64 | 93.85 | -4.12 | 156.77 |
Unlevered Free Cash Flow | 92.41 | 95.17 | -34.95 | 72.41 | 68.56 | 8.42 |